# Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

> **NCT01000064** · PHASE3 · TERMINATED · sponsor: **Vanderbilt University** · enrollment: 22 (actual)

## Conditions studied

- Traumatic Brain Injury
- Attention Deficit Disorder

## Interventions

- **DRUG:** Vyvanse
- **PROCEDURE:** fMRI
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01000064
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2013-12
- **Final completion:** 2015-05
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** unable to meet recruitment goals
- **Last updated:** 2017-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01000064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01000064, "Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01000064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*